以基因型抗生素耐药性为导向的精密疗法用于杆菌根除:一项前性随机对照试验
Yan Xu1, Jing-Wen Hao1, Cong-Cong Min1
1Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, China.
基因型抗生素敏感性测试 (G-AST) 导向治疗显著改善了Helicobacter pylori根除率,相比于标准木四倍疗法. 这种精确的方法提供了更有效的第一线治疗,而不会增加不良事件.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 临床微生物学 临床微生物学
背景情况:
- 杆菌 (H. pylori) 是致癌物,但抗生素耐药性的增加降低了治疗的有效性.
- 根据"马斯特里赫特六号/佛罗伦萨共识",将H. pylori的治疗量身定制为局部耐药性模式至关重要.
研究的目的:
- 以基因型抗生素敏感性测试 (G-AST) 为指导,评估一线H. pylori治疗的有效性.
主要方法:
- 一项随机对照试验将14天的G-AST引导治疗与194名H. pylori阳性患者的标准木四倍疗法 (BQT) 相比较.
- 基于个体敏感性的G-AST指导的抗生素选择 (克拉里素,勒沃素或四环素).
- 使用治疗意图 (ITT) 和每协议 (PP) 分析来评估疗效和不良事件.
主要成果:
- 在ITT (92.8%对79.4%,P=0.007) 和PP (97.8%对84.1%,P=0.001) 分析中,G-AST组的根除率显著更高.
- 有利于G-AST的风险差异为13.4% (ITT) 和13.7% (PP).
- 在G-AST和BQT组之间,不良事件发生率相似 (30.9%与28.9%,P=0.754).
结论:
- 在第一线的H. pylori根除中,G-AST引导的治疗优于经验BQT.
- 个性化,耐药导向的治疗可以提高临床结果,而不会影响安全.
- 支持G-AST在优化H. pylori治疗策略中的实用性.
更多相关视频
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
